Healthcare >> CEO Interviews >> October 1, 2001
BRIAN M. GALLAGHER is currently Chairman, President and Chief Executive
Officer of CollaGenex Pharmaceuticals, Inc., a publicly traded,
profitable, specialty pharmaceutical company located in Newtown,
Pennsylvania. Dr. Gallagher also currently serves as a Director of Adams
Laboratories, Inc., a privately held, specialty pharmaceutical company
in the respiratory and allergy fields and ImaRx Therapeutics, Inc., a
privately held, drug delivery/specialty pharmaceutical company with an
initial focus on cardiovascular disease. He was also formerly a Director
of Acusphere, Inc., a privately held, drug delivery technology company.
Dr. Gallagher was formerly President of Squibb Diagnostics, a division
of Bristol-Myers Squibb Company in Princeton, New Jersey, from 1991
until joining CollaGenex in 1994. Prior to that, he served in various
executive management positions, including Vice President of Marketing
and Worldwide Business Development at Bristol-Myers Squibb. From 1978
until 1988, Dr. Gallagher served with increasing responsibilities in
various research, development, business development and marketing
positions with the Pharmaceuticals Division of E.I. du Pont de Nemours
Company, Inc. and its predecessor New England Nuclear Corporation. Prior
to DuPont, from 1974 until 1978, Dr. Gallagher served as a Research
Scientist in the Chemistry Department of Brookhaven National Laboratory.
He is the author of numerous scientific publications, review articles
and book chapters. Dr. Gallagher holds a Bachelor of Science degree in
Biology from St. Louis University (1969), a Master of Science degree in
Marine Science from Long Island University (1971) and a Doctor of
Philosophy degree with a concentration in Biochemistry and Cell
Physiology (1974) from St. John's University. Profile
of CollaGenex as it is now?
Dr. Gallagher: The company was founded in 1992 and will celebrate its
tenth anniversary next
